BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saul S, Karim M, Huang PT, Ghita L, Chiu W, Kumar S, Bhalla N, Leyssen P, Cohen CA, Huie K, Tindle C, Sibai M, Pinsky BA, Das S, Ghosh P, Dye JM, Solow-Cordero DE, Jin J, Jochmans D, Neyts J, Narayanan A, De Jonghe S, Einav S. Discovery of pan-ErbB inhibitors protecting from SARS-CoV-2 replication, inflammation, and lung injury by a drug repurposing screen. bioRxiv 2021:2021. [PMID: 34159337 DOI: 10.1101/2021.05.15.444128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mcauley AJ, Jansen van Vuren P, Mohammed M, Faheem, Goldie S, Riddell S, Gödde NJ, Styles IK, Bruce MP, Chahal S, Keating S, Blasdell KR, Tachedjian M, O’brien CM, Singanallur NB, Viana JN, Vashi AV, Kirkpatrick CM, Macraild CA, Shah RM, Vincan E, Athan E, Creek DJ, Trevaskis NL, Murugesan S, Kumar A, Vasan SS. Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection. Viruses 2022;14:2417. [DOI: 10.3390/v14112417] [Reference Citation Analysis]
2 Karim M, Saul S, Ghita L, Sahoo MK, Ye C, Bhalla N, Jin J, Park J, Martinez-gualda B, East MP, Johnson GL, Pinsky BA, Martinez-sobrido L, Asquith CRM, Narayanan A, De Jonghe S, Einav S. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for therapy.. [DOI: 10.1101/2022.03.18.484178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Barbagallo D, Palermo CI, Barbagallo C, Battaglia R, Caponnetto A, Spina V, Ragusa M, Di Pietro C, Scalia G, Purrello M. Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells. Cell Mol Life Sci 2022;79:75. [PMID: 35039944 DOI: 10.1007/s00018-021-04119-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 White JM, Schiffer JT, Bender Ignacio RA, Xu S, Kainov D, Ianevski A, Aittokallio T, Frieman M, Olinger GG, Polyak SJ, Prasad VR. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio 2021;12:e03347-21. [DOI: 10.1128/mbio.03347-21] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 18.0] [Reference Citation Analysis]
5 Kochat V, Raman AT, Landers SM, Tang M, Schulz J, Terranova C, Landry JP, Bhalla AD, Beird HC, Wu CC, Jiang Y, Mao X, Lazcano R, Gite S, Ingram DR, Yi M, Zhang J, Keung EZ, Scally CP, Roland CL, Hunt KK, Feig BW, Futreal PA, Hwu P, Wang WL, Lazar AJ, Slopis JM, Wilson-Robles H, Wiener DJ, McCutcheon IE, Wustefeld-Janssens B, Rai K, Torres KE. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol 2021;142:565-90. [PMID: 34283254 DOI: 10.1007/s00401-021-02341-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]